bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) shares traded up 1.9% during trading on Tuesday . The company traded as high as $1.58 and last traded at $1.09. 18,856 shares traded hands during mid-day trading, an increase of 296% from the average session volume of 4,767 shares. The stock had previously closed at $1.07.
bioAffinity Technologies Stock Performance
The firm has a 50-day moving average price of $1.26 and a two-hundred day moving average price of $0.76.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Featured Articles
- Five stocks we like better than bioAffinity Technologies
- Stock Sentiment Analysis: How it Works
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- How to Invest in the Best Canadian Stocks
- AMD Gains Momentum With AI: Can It Beat Expectations?
- 3 Small Caps With Big Return Potential
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
